Strengthening Investment Engagement in Rwanda Exon Genetic & Biotechnology and BEYLER GROUP have continued to engage with institutions in Rwanda as part of their interest in healthcare and investment opportunities in the country. On April 7, 2023, BEYLER GROUP Chairman of the Board Dr. Hulusi Söğütlü and Exon’s Rwanda representative
Strengthening Healthcare Investment and Biotechnology Cooperation in Rwanda Exon Genetic & Biotechnology continues to pursue opportunities that contribute to the development of healthcare, medical technology and biotechnology across Africa. As part of this commitment, the company’s leadership held an important meeting with Rwanda’s Deputy Minister of Health, Dr. Yvan Butera,
